Baishen Zhang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Locally Advanced

Cross Sectional

Chemotherapy Induced

Top Venues

International journal of cancer

Journal of inflammation research

This page only lists publications with an associated author ORCID identifier.

Publications

Baishen Zhang, Yao Liu, Zhiting Chen, Jing Chen, Hui Yu, Meichen Li, Shudong Ma, Chao Cheng, Li-Kun Chen
Chemotherapy versus chemotherapy plus immune checkpoint inhibitors for the first-line treatment of unresectable thymic carcinoma: A multicenter retrospective study. International journal of cancer 155 (4) (2024)
Baishen Zhang, Jing Chen, Hui Yu, Meichen Li, Muyan Cai, Li-Kun Chen
Prognostic Nutritional Index Predicts Efficacy and Immune-Related Adverse Events of First-Line Chemoimmunotherapy in Patients with Extensive-Stage Small-Cell Lung Cancer. Journal of inflammation research 17 (2024)
Baishen Zhang, Jing Chen, Hui Yu, Meichen Li, Muyan Cai, Li-Kun Chen
Prognostic Nutritional Index Predicts Efficacy and Immune-Related Adverse Events of First-Line Chemoimmunotherapy in Patients with Extensive-Stage Small-Cell Lung Cancer. Journal of inflammation research 17 (2024)
Baishen Zhang, Yao Liu, Zhiting Chen, Jing Chen, Hui Yu, Meichen Li, Shudong Ma, Chao Cheng, Li-Kun Chen
Chemotherapy versus chemotherapy plus immune checkpoint inhibitors for the first-line treatment of unresectable thymic carcinoma: A multicenter retrospective study. International journal of cancer 155 (4) (2024)
Baishen Zhang, Yao Liu, Zhiting Chen, Jing Chen, Hui Yu, Meichen Li, Shudong Ma, Chao Cheng, Li-Kun Chen
Chemotherapy versus chemotherapy plus immune checkpoint inhibitors for the first-line treatment of unresectable thymic carcinoma: A multicenter retrospective study. International journal of cancer (2024)